CAFC Invalidates Functionally Claimed Antibody Patents as Lacking Written Description

On July 1, 2014, the Court of Appeals for the Federal Circuit (CAFC) decided AbbVie Deutschland GmbH v. Janssen Biotech, Inc., holding that a genus claimed solely by functional language that defines a desired result requires the written description…
By: Brownstein Hyatt Farber Schreck